Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Vis Exp. 2019 Apr 10;(146):10.3791/59320. doi: 10.3791/59320

Figure 3: Intramyocardial delivery of MPC-Exo partially recovers dystrophin expression in MDX hearts, and improves heart function measured by echocardiography.

Figure 3:

(A) Confocal immunofluorescent staining the heart sections of MDX mice 2 days after intramyocardial PBS/ MPC-Exo delivery. Blue = DAPI, Green = anti-dystrophin antibody. (B) Echocardiographic measurements of cardiac function after 2 days of PBS/ MPC-Exo treatment.